Schnell Biopharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
21,650
20,830
24,604
57,731
24,742
38,653
Total Accounts Receivable
13,689
19,542
17,657
16,860
32,061
40,068
Inventories
5,711
6,671
6,490
8,114
8,836
8,399
Other Current Assets
2,354
1,541
386
363
368
168
Total Current Assets
43,404
48,582
49,137
83,069
66,008
87,287
Net Property, Plant & Equipment
21,200
22,587
25,111
25,948
18,164
17,327
Total Investments and Advances
11,107
11,496
5,863
13,610
68,437
107,946
Long-Term Note Receivable
-
-
120
120
-
461
Intangible Assets
1,973
2,163
4,126
4,893
4,518
3,290
Other Assets
575
-
-
382
448
-
Total Assets
78,259
84,828
85,221
128,691
158,272
217,062
ST Debt & Current Portion LT Debt
2,372
5,661
4,523
35,961
26,757
Accounts Payable
601
342
654
520
489
Income Tax Payable
-
18
200
358
192
Other Current Liabilities
6,571
4,379
4,508
8,310
6,531
Total Current Liabilities
9,545
10,399
9,885
45,150
33,970
Long-Term Debt
8,332
8,395
4,139
1,080
24,894
Provision for Risks & Charges
2,477
2,561
2,046
2,954
3,447
Deferred Taxes
-
-
863
669
697
Other Liabilities
1,359
1,359
1,406
1,386
18,101
Total Liabilities
21,712
22,715
17,476
50,570
80,411
Common Equity (Total)
56,255
62,330
69,225
80,405
77,861
Total Shareholders' Equity
56,255
62,330
69,225
80,405
77,861
Total Equity
56,547
62,113
67,745
78,120
77,861
Liabilities & Shareholders' Equity
78,259
84,828
85,221
128,691
158,272
Accumulated Minority Interest
292
216
1,480
2,284
-
About Schnell Biopharmaceuticals
View Profile
